News
JNJ offers resilience and income, while Apple fuels long-term growth???ideal picks for a stress-free retirement portfolio.
3d
Zacks Investment Research on MSNHere is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending StockJohnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
Johnson & Johnson (NYSE:JNJ) is one of the top cheap pharmaceutical stocks to buy now. On July 29, Johnson & Johnson ...
7d
Zacks.com on MSNJNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.
Kenvue cut its annual sales forecast on Thursday, as the consumer health company undergoes a strategic review aiming to boost ...
23d
MarketBeat on MSNJNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is NowDetailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Johnson & Johnson JNJ will report fourth-quarter and full-year 2022 results on Jan 24, before market open. In the last reported quarter, the company delivered an earnings surprise of 2.41%.
JNJ offers a dividend yield of 3.1%.ConclusionWall Street analysts are very bullish about Intuitive Surgical and are cautiously optimistic about Eli Lilly and Johnson & Johnson.
The stock price of Johnson & Johnson has outperformed the broader indices over the last month or so. While the S&P500 index has seen a rise of 1% over the last one month, JNJ stock is up around 5% ...
JNJ, AbbVie plan to pull US accelerated approvals for some blood cancer treatments By Reuters April 6, 20233:35 PM PDTUpdated April 6, 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results